NCT02751034View on ClinicalTrials.gov

Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

January 31, 2014

Conditions
Nasolabial Fold
Interventions
DEVICE

Neuramis® Deep Lidocaine

HA filler

DEVICE

Restylane® PERLANE-L

HA filler

Trial Locations (2)

130-709

Catholic University St. Paul Hospital, Seoul

156-755

Chung-Ang Univ. Medical Center, Seoul

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT02751034 - Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold | Biotech Hunter | Biotech Hunter